Highlights Cigna

Equities

CI

US1255231003

Managed Healthcare

Market Closed - Nyse Other stock markets 21:00:02 06/02/2026 GMT			5-day change	1st Jan Change
292.05 ^USD	+2.64%		+6.54%	+6.11%

02-06	Cigna Shows Greater Stability Amid Policy Uncertainty, RBC Says	MT
02-06	RBC Trims Price Target on Cigna Group to $333 From $344, Keeps Outperform Rating	MT

Highlights

02-05	The Cigna Group Declares Quarterly Dividend, Payable on March 19, 2026	CI
02-05	Sector Update: Health Care Stocks Lean Lower Premarket Thursday	MT
02-05	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Amazon Earnings	MT
02-05	Cigna beats quarterly estimates, provides muted outlook	RE
02-05	Cigna reports Q4 adjusted EPS $8.08	RE
02-05	Stocks Rise Pre-Bell Ahead of Key Labor Market Data, Amazon Earnings	MT
02-05	Cigna 2026 forecast misses Wall Street expectations	RE
02-05	Cigna Q4 Adjusted Income, Revenue Rise; 2026 Outlook Set	MT
02-05	(CI) Cigna Expects 2026 Adjusted Revenue About $280B, vs. FactSet Est of $285.86B	MT
02-05	(CI) Cigna Expects 2026 Adjusted EPS at Least $30.25, vs. FactSet Est of $30.30	MT
02-05	Earnings Flash (CI) Cigna Posts Q4 Adjusted Revenue $72.5B, vs. FactSet Est of $70.31B	MT
02-05	Earnings Flash (CI) Cigna Posts Q4 Adjusted EPS $8.08, vs. FactSet Est of $7.88	MT
02-05	North American Morning Briefing : Futures Appear Split Between Small Gains and Losses -2-	DJ
02-05	Cigna Posts 4Q Revenue Rise on Growth of Evernorth Business	DJ
02-05	Tranche Update on The Cigna Group (NYSE:CI)'s Equity Buyback Plan announced on December 20, 2018.	CI
02-05	PRESS DIGEST-New York Times business news - February 5	RE
02-04	Cigna settles FTC insulin case, aims to lower drug prices	RE
02-04	Cigna settles FTC insulin case, aims to lower drug prices	RE
02-04	Cigna settles FTC insulin case, commits to overhauling drug pricing	RE
02-04	Sector Update: Health Care Stocks Rise Wednesday Afternoon	MT
02-04	Cigna's Express Scripts Settles With FTC	MT
02-04	Cigna's Express Scripts Settles With FTC	MT
02-04	Cigna's Express Scripts settles US Federal Trade Commission's insulin pricing claims - document seen by Reuters	RE
02-03	The Cigna Group Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-12	Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Cigna Won't Pursue Humana Merger

November 11, 2024 at 08:28 pm